AQA
DGX icon

Alpha Quant Advisors’s Quest Diagnostics DGX Stock Holding History

Alpha Quant Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$252K Buy
+2,807
New +$243K 0.25% 104

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha Quant Advisors's DGX Position: Q1 2019 in Review

Alpha Quant Advisors opened a new position in Quest Diagnostics (DGX) in Q1 2019: 2,807 shares worth $252K. The stake represents 0.25% of the portfolio and ranks #104 among its holdings.

656 funds tracked by Wall St. Rank hold DGX as of Q1 2019.

  • Alpha Quant Advisors held 2,807 shares of Quest Diagnostics worth $252K as of Q1 2019.
  • Quest Diagnostics was a new Alpha Quant Advisors position in Q1 2019.
  • Quest Diagnostics made up 0.25% of Alpha Quant Advisors's portfolio in Q1 2019, its #104 holding.
  • 656 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.